Dilek Dogan Gurluk wants to know what Irish summers are like. The new general manager of Novo Nordisk’s Irish operation arrived here just before Christmas and, like the rest of us, has barely seen the ...

Frontotemporal dementia (FTD), in particular, may be at play, and identifying ways to slow down its progression can help. In ...

At a health plan for private school employees in Pennsylvania, pharmacy expenses are expected to hit 30% of total healthcare costs this year. Drug costs have risen faster than medical expenses since ...

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

A new study suggests that almost half of people stopping GLP-1 weight-loss drugs may keep the weight off. However, many of these people continued other forms of treatment after stopping GLP-1 drugs.

As part of an investigation that dates back to 2023, the FDA has identified over two dozen products featuring the plant.

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

One pill for obesity is already on the market, and more are on the way. But the injected drugs have key advantages.

Dermatologists and plastic surgeons say ‘Ozempic face’ is nothing new. Rapid weight loss has always led to skin changes. Here are the treatments they recommend for restoring skin texture and fullness.

GKOS launches Epioxa, the first FDA-approved topical keratoconus therapy, targeting an underserved market and positioning the company for long-term growth.

Can you scream your way to happiness? Maybe not, but the scream clubs popping up around the U.S. promise some relief.

The planned Shanghai facility extends a yearslong push into the field and will support CAR-T therapies AstraZeneca is making for autoimmune disease and cancer.